These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 11917236)

  • 21. Multilaboratory comparison of hepatitis C virus viral load assays.
    Caliendo AM; Valsamakis A; Zhou Y; Yen-Lieberman B; Andersen J; Young S; Ferreira-Gonzalez A; Tsongalis GJ; Pyles R; Bremer JW; Lurain NS
    J Clin Microbiol; 2006 May; 44(5):1726-32. PubMed ID: 16672399
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of four commercial quantitative HIV-1 assays for viral load monitoring in clinical daily routine.
    Braun P; Ehret R; Wiesmann F; Zabbai F; Knickmann M; Kühn R; Thamm S; Warnat G; Knechten H
    Clin Chem Lab Med; 2007; 45(1):93-9. PubMed ID: 17243923
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical comparison of branched DNA and reverse transcriptase-PCR and nucleic acid sequence-based amplification assay for the quantitation of circulating recombinant form_BC HIV-1 RNA in plasma.
    Pan P; Tao X; Zhang Q; Xing W; Sun X; Pei L; Jiang Y
    AIDS; 2007 Dec; 21 Suppl 8():S27-32. PubMed ID: 18172387
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Evaluation of the clinical sensitivity for the quantification of human immunodeficiency virus type 1 RNA in plasma: Comparison of the new COBAS TaqMan HIV-1 with three current HIV-RNA assays--LCx HIV RNA quantitative, VERSANT HIV-1 RNA 3.0 (bDNA) and COBAS AMPLICOR HIV-1 Monitor v1.5.
    Katsoulidou A; Petrodaskalaki M; Sypsa V; Papachristou E; Anastassopoulou CG; Gargalianos P; Karafoulidou A; Lazanas M; Kordossis T; Andoniadou A; Hatzakis A
    J Virol Methods; 2006 Feb; 131(2):168-74. PubMed ID: 16194575
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The significance of HIV viral load assay precision: a review of the package insert specifications of two commercial kits.
    Chernoff DN
    J Int Assoc Physicians AIDS Care (Chic); 2002; 1(4):134-40. PubMed ID: 12942672
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High correlation between the Roche COBAS® AmpliPrep/COBAS® TaqMan® HIV-1, v2.0 and the Abbott m2000 RealTime HIV-1 assays for quantification of viral load in HIV-1 B and non-B subtypes.
    Karasi JC; Dziezuk F; Quennery L; Förster S; Reischl U; Colucci G; Schoener D; Seguin-Devaux C; Schmit JC
    J Clin Virol; 2011 Nov; 52(3):181-6. PubMed ID: 21813320
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of HIV type 1 subtype variation on viral RNA quantitation.
    Parekh B; Phillips S; Granade TC; Baggs J; Hu DJ; Respess R
    AIDS Res Hum Retroviruses; 1999 Jan; 15(2):133-42. PubMed ID: 10029245
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Quantitation of human immunodeficiency virus type 1 (HIV-1) RNA in cell-free cervicovaginal secretions: comparison of reverse transcription-PCR amplification (AMPLICOR HIV-A MONITOR 1.5) with enhanced-sensitivity branched-DNA assay (Quantiplex 3.0).
    Si-Mohamed A; Andreoletti L; Colombet I; Carreno MP; Lopez G; Chatelier G; Kazatchkine MD; Belec L
    J Clin Microbiol; 2001 Jun; 39(6):2055-9. PubMed ID: 11376034
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multicenter evaluation of the Bayer VERSANT HIV-1 RNA 3.0 assay: analytical and clinical performance.
    Gleaves CA; Welle J; Campbell M; Elbeik T; Ng V; Taylor PE; Kuramoto K; Aceituno S; Lewalski E; Joppa B; Sawyer L; Schaper C; McNairn D; Quinn T
    J Clin Virol; 2002 Aug; 25(2):205-16. PubMed ID: 12367656
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Low-level viremia associated with the use of TaqMan assay.
    Szabo S; Moffett LE; Cantwell-McNelis K; James CW; Joseph A
    J Int Assoc Physicians AIDS Care (Chic); 2010; 9(4):203-5. PubMed ID: 20530465
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the clinical sensitivities of three viral load assays with plasma samples from a pediatric population predominantly infected with human immunodeficiency virus type 1 subtype G and BG recombinant forms.
    Antunes R; Figueiredo S; Bártolo I; Pinheiro M; Rosado L; Soares I; Lourenço H; Taveira N
    J Clin Microbiol; 2003 Jul; 41(7):3361-7. PubMed ID: 12843094
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Impact of human immunodeficiency virus type 1 (HIV-1) genetic diversity on performance of four commercial viral load assays: LCx HIV RNA Quantitative, AMPLICOR HIV-1 MONITOR v1.5, VERSANT HIV-1 RNA 3.0, and NucliSens HIV-1 QT.
    Swanson P; de Mendoza C; Joshi Y; Golden A; Hodinka RL; Soriano V; Devare SG; Hackett J
    J Clin Microbiol; 2005 Aug; 43(8):3860-8. PubMed ID: 16081923
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A sensitive branched DNA HIV-1 signal amplification viral load assay with single day turnaround.
    Baumeister MA; Zhang N; Beas H; Brooks JR; Canchola JA; Cosenza C; Kleshik F; Rampersad V; Surtihadi J; Battersby TR
    PLoS One; 2012; 7(3):e33295. PubMed ID: 22479381
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Comparative evaluation of the VERSANT HCV RNA 3.0, QUANTIPLEX HCV RNA 2.0, and COBAS AMPLICOR HCV MONITOR version 2.0 Assays for quantification of hepatitis C virus RNA in serum.
    Germer JJ; Heimgartner PJ; Ilstrup DM; Harmsen WS; Jenkins GD; Patel R
    J Clin Microbiol; 2002 Feb; 40(2):495-500. PubMed ID: 11825962
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Performance characteristics of the QUANTIPLEX HIV-1 RNA 3.0 assay for detection and quantitation of human immunodeficiency virus type 1 RNA in plasma.
    Erice A; Brambilla D; Bremer J; Jackson JB; Kokka R; Yen-Lieberman B; Coombs RW
    J Clin Microbiol; 2000 Aug; 38(8):2837-45. PubMed ID: 10921936
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Discordance between viral loads determined by Roche COBAS AMPLICOR human immunodeficiency virus type 1 monitor (version 1.5) Standard and ultrasensitive assays caused by freezing patient plasma in centrifuged becton-dickinson vacutainer brand plasma preparation tubes.
    Salimnia H; Moore EC; Crane LR; Macarthur RD; Fairfax MR
    J Clin Microbiol; 2005 Sep; 43(9):4635-9. PubMed ID: 16145119
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the new LCx HIV RNA quantitative assay: comparison with the Cobas Amplicor HIV Monitor assay.
    Berger A; Rabenau HF; Stief A; Troonen H; Doerr HW
    Med Microbiol Immunol; 2001 Dec; 190(3):129-34. PubMed ID: 11827201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Comparison of qualitative (COBAS AMPLICOR HCV 2.0 versus VERSANT HCV RNA) and quantitative (COBAS AMPLICOR HCV monitor 2.0 versus VERSANT HCV RNA 3.0) assays for hepatitis C virus (HCV) RNA detection and quantification: impact on diagnosis and treatment of HCV infections.
    Desombere I; Van Vlierberghe H; Couvent S; Clinckspoor F; Leroux-Roels G
    J Clin Microbiol; 2005 Jun; 43(6):2590-7. PubMed ID: 15956369
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Comparison of the RealTime HIV-1, COBAS TaqMan 48 v1.0, Easy Q v1.2, and Versant v3.0 assays for determination of HIV-1 viral loads in a cohort of Canadian patients with diverse HIV subtype infections.
    Church D; Gregson D; Lloyd T; Klein M; Beckthold B; Laupland K; Gill MJ
    J Clin Microbiol; 2011 Jan; 49(1):118-24. PubMed ID: 21084515
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative evaluation of the VERSANT HIV-1 RNA 1.0 kinetic PCR molecular system (kPCR) for the quantification of HIV-1 plasma viral load.
    Ruelle J; Jnaoui K; Lefèvre I; Lamarti N; Goubau P
    J Clin Virol; 2009 Apr; 44(4):297-301. PubMed ID: 19230753
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.